Abstract:Since many complex physiological processes are controlled by multiple biomolecules, comprehensive regulation of bone tissue regeneration may be more effectively achieved by administering more than one type of biofactor. Thus, we propose a novel bone tissue engineering scaffold incorporating a multiple peptide-based drug delivery vehicle for accelerated bone regeneration. Pore-closed poly(lactic-co-glycolic acid) (PLGA) microspheres with a surface structure of multilayer polyelectrolytes ((Ha-Cs) 2-Hep-BMP-2-Hep( Cs-Ha) 2) were prepared as multi-barrier microcarriers for osteogenic growth peptide (OGP). In addition, BMP-2 loading was achieved via a pore-closing process and layer-by-layer (LbL) assembly technique, followed by immobilization on the surface of a highly interconnected porous hydroxyapatite (HA) scaffold. On the basis of such a construction, sequential delivery of OGP and BMP-2 occurred in a coordinated manner through an orchestrated sequence of spatial changes, targeting different bone healing stages. The in vitro studies showed that OGP release was minimal (<11.7%) in the first 15 d but accelerated remarkably thereafter, while at least 56.3% of BMP-2 payload was released at this time and subsequent release was only marginal. In addition, scaffolds carrying dual-biofactor exhibited a stronger ability to induce bone marrow mesenchymal stem cell (BMSC) differentiation toward osteoblasts than those incorporating OGP or BMP-2 alone and factor-free scaffolds in terms of alkaline phosphatase (ALP) activity and osteogenic gene and protein (Runx2, COL I, and OCN) expression. The results of in vitro cell culturing demonstrated the roles of BMP-2 in osteogenic differentiation early as well as the effect of OGP on accelerated proliferation and maturation of osteoblast precursors at a later stage. Further in vivo osteogenesis studies also revealed that the dual biofactor-loaded scaffold manifested the best repair efficacy due to a potential synergistic effect of BMP-2 and OGP. Collectively, our findings suggested that such a dual delivery system may provide a therapeutic strategy sequentially targeting multiple events or mechanisms during bone healing and was proved to be a promising therapeutic scaffold for future use in bone tissue regeneration.

Brasenia -inspired hydrogel with sustained and sequential release of BMP and WNT activators for improved bone regeneration

Click-based injectable bioactive PEG-hydrogels guide rapid craniomaxillofacial bone regeneration by the spatiotemporal delivery of rhBMP-2

Accelerated Bone Regenerative Efficiency by Regulating Sequential Release of BMP-2 and VEGF and Synergism with Sulfated Chitosan.

Cascaded controlled delivering growth factors to build vascularized and osteogenic microenvironment for bone regeneration

Spatiotemporal regulation of angiogenesis/osteogenesis emulating natural bone healing cascade for vascularized bone formation

Injectable hydrogel systems with multiple biophysical and biochemical cues for bone regeneration

A dual-responsive polydopamine-modified hydroxybutyl chitosan hydrogel for sequential regulation of bone regeneration

A Dual Reversible Cross-Linked Hydrogel with Enhanced Mechanical Property And Capable of Proangiogenic and Osteogenic Activities for Bone Defect Repair.

Sequential Dual-Biofactor Release from the Scaffold of Mesoporous HA Microspheres and PLGA Matrix for Boosting Endogenous Bone Regeneration

Biomimetic nanofibrous hybrid hydrogel membranes with sustained growth factor release for guided bone regeneration

<i>In situ</i> mineralized PLGA/zwitterionic hydrogel composite scaffold enables high-efficiency rhBMP-2 release for critical-sized bone healing

Sustained Protein Therapeutics Enabled by Self-Healing Nanocomposite Hydrogels for Non-Invasive Bone Regeneration.

Multiscale design of stiffening and ROS scavenging hydrogels for the augmentation of mandibular bone regeneration

Alendronate-functionalized double network hydrogel scaffolds for effective osteogenesis

Injectable thermo-responsive Poloxamer hydrogel/methacrylate gelatin microgels stimulates bone regeneration through biomimetic programmed release of SDF-1a and IGF-1

Pathogenesis‐Guided Engineering of Multi‐Bioactive Hydrogel Co‐Delivering Inflammation‐Resolving Nanotherapy and Pro‐Osteogenic Protein for Bone Regeneration

Advancements in Hydrogel-Based Drug Sustained Release Systems for Bone Tissue Engineering.

Biomimetic dually cross-linked injectable poly(l-glutamic acid) based nanofiber composite hydrogels with self-healing, osteogenic and angiogenic properties for bone regeneration

Programmed Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 and Inorganic Ion Composite Hydrogel As Artificial Periosteum

Enhanced Osteogenesis of Multilayered Pore-Closed Microsphere-Immobilized Hydroxyapatite Scaffold Via Sequential Delivery of Osteogenic Growth Peptide and BMP-2

Biomimetic management of bone healing stages: MOFs induce tunable degradability and enhanced angiogenesis-osteogenesis coupling